News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Keryx Biopharmaceuticals Announces Appointment Of Jack Kaye, CPA, To Board Of Directors
September 20, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX - News) today announced the appointment of Jack Kaye, CPA, to the Company's Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
April 23, 2025
·
1 min read
·
Tristan Manalac
Podcast
Makary’s First Interview, US Manufacturing Push and Lilly vs. Novo in Obesity Pill Race
April 23, 2025
·
1 min read
·
Heather McKenzie
C-suite
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
April 22, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Tempest Axes 80% of Workforce
April 22, 2025
·
180 min read
·
BioSpace Editorial Staff
